Phase 1 Trial of SBS-147 in Healthy Adults
Phase 1
80
about 1.1 years
18–55
1 site in CA
What this study is about
This trial is testing the safety and how people's bodies react to SBS-147. Participants will receive either SBS-147 or a placebo, which looks like SBS-147 but has no medicine. The study involves both a single dose and multiple doses of SBS-147 over 409 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebo
- 2.Take SBS-147
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Number of participants with treatment-related adverse events as assessed by CTCAE v5.0, Number of participants with treatment-related adverse events as assessed by CTCAE v5.0 at ascending doses
Secondary: Plasma pharmacokinetics of SBS-1000 and SBS-147 following multiple ascending doses